CIK: 0001019231 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 6, 2022
Total Value ($000): $194,210 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BBRE | JPM BETABLDRS MSCI US REIT | 1,422,838 | $151,390 | 78.0% | $105.60 | — | ETFS | 46641Q738 |
| — | ELLIOTT OPPORTUNITY II CORP | 2,000,000 | $19,720 | 10.2% | $10.01 | — | COM | G30092129 |
| TXN | TEXAS INSTRUMENTS INC | 32,000 | $5,871 | 3.0% | $57.24 | +174.8% | COM | 882508104 |
| IMTX | IMMATICS NV | 697,431 | $5,572 | 2.9% | $10.53 | -13.5% | COM | N44445109 |
| — | CODIAK BIOSCIENCES INC | 847,108 | $5,311 | 2.7% | $15.08 | — | COM | 192010106 |
| VT | VANGUARD TOT WORLD STK ETF | 31,684 | $3,209 | 1.7% | $80.77 | — | ETFS | 922042742 |
| BOND | PIMCO ACTIVE BOND EXCHANGE-T | 13,775 | $1,402 | 0.7% | $109.40 | — | COM | 72201R775 |
| — | AEGLEA BIOTHERAPEUTICS INC | 245,678 | $565 | 0.3% | $6.41 | — | COM | 00773J103 |
| DVN | DEVON ENERGY CORP | 8,334 | $493 | 0.3% | $44.56 | 0.0% | COM | 25179M103 |
| — | PLX PHARMA INC | 62,673 | $253 | 0.1% | $6.14 | — | COM | 72942A107 |
| — | TFF PHARMACEUTICALS INC | 22,066 | $139 | 0.1% | $18.47 | — | COM | 87241J104 |
| — | APOLLO ENDOSURGERY INC | 15,601 | $94 | 0.0% | $2.24 | — | COM | 03767D108 |
| BX | BLACKSTONE INC | 633 | $80 | 0.0% | $107.20 | 0.0% | COM | 09260D107 |
| LXRX | LEXICON PHARMACEUTICALS INC | 35,714 | $75 | 0.0% | $7.34 | -62.3% | COM | 528872302 |
| MSFT | MICROSOFT CORP | 85 | $26 | 0.0% | $290.64 | +0.3% | COM | 594918104 |
| POR | PORTLAND GENERAL ELECTRIC CO | 118 | $7 | 0.0% | $20.00 | +121.8% | COM | 736508847 |
| EVTC | EVERTEC, INC. | 80 | $3 | 0.0% | $42.00 | 0.0% | COM | 30040P103 |